Ontology highlight
ABSTRACT: Objective
Identify the potential for and risk factors of SARS-CoV-2 vertical transmission.Methods
Symptomatic pregnant women with COVID-19 diagnosis in whom PCR for SARS-CoV-2 was performed at delivery using maternal serum and at least one of the biological samples: cord blood (CB), amniotic fluid (AF), colostrum and/or oropharyngeal swab (OPS) of the neonate. The association of parameters with maternal, AF and/or CB positivity and the influence of SARS-CoV-2 positivity in AF and/or CB on neonatal outcomes were investigated.Results
Overall 73.4% (80/109) were admitted in hospital due to COVID-19, 22.9% needed intensive care and there were four maternal deaths. Positive RT-PCR for SARS-CoV-2 was observed in 14.7% of maternal blood, 13.9% of AF, 6.7% of CB, 2.1% of colostrum and 3.7% of OPS samples. The interval between COVID-19 symptoms and delivery was inversely associated with SARS-CoV-2 positivity in the maternal blood (p = 0.002) and in the AF and/or CB (p = 0.049). Maternal viremia was associated with positivity for SARS-CoV-2 in AF and/or CB (p = 0.001). SARS-CoV-2 positivity in the compartments was not associated with neonatal outcomes.Conclusion
Vertical transmission is possible in pregnant women with COVID-19 and a shorter interval between maternal symptoms and delivery is an influencing factor.
SUBMITTER: Maeda MFY
PROVIDER: S-EPMC8242902 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
Maeda Mariane de Fátima Yukie MFY Brizot Maria de Lourdes ML Gibelli Maria Augusta Bento Cicaroni MABC Ibidi Silvia Maria SM Carvalho Werther Brunow de WB Hoshida Mara Sandra MS Machado Clarisse Martins CM Sabino Ester Cerdeira EC Oliveira da Silva Lea Campos de LC Jaenisch Thomas T Mendes-Correa Maria Cássia Jacintho MCJ Mayaud Philippe P Francisco Rossana Pulcinelli Vieira RPV
Prenatal diagnosis 20210614 8
<h4>Objective</h4>Identify the potential for and risk factors of SARS-CoV-2 vertical transmission.<h4>Methods</h4>Symptomatic pregnant women with COVID-19 diagnosis in whom PCR for SARS-CoV-2 was performed at delivery using maternal serum and at least one of the biological samples: cord blood (CB), amniotic fluid (AF), colostrum and/or oropharyngeal swab (OPS) of the neonate. The association of parameters with maternal, AF and/or CB positivity and the influence of SARS-CoV-2 positivity in AF and ...[more]